DICE(Delisted)
DICE TherapeuticsยทNASDAQ
--
--(--)
DICE Profile
Dice Therapeutics, Inc.
A biopharmaceutical company that designs and develops oral therapeutic candidates to treat chronic diseases
400 East Jamie Court, Suite 300, South San Francisco, California 94080
--
DICE Therapeutics, Inc., was incorporated in Delaware on August 14, 2013. The Company is a biopharmaceutical company that leverages its proprietary technology platform to build a portfolio of novel oral therapies for the treatment of chronic diseases in immunology and other therapeutic areas. The company initially focused on developing oral therapies against well-proven targets in immunology, with the goal of achieving the same effect as the systemic biological counterpart, which has proven to date to have the greatest therapeutic benefit in these disease areas.
